| (Mark One) |
| [|X|] | Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
| For the fiscal year ended December 31, 2002 or |
| [ ] | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
| For the period from __________ to __________ |
| Commission file number | 1-10207 |
ALARIS MEDICAL
SYSTEMS, INC.
(formerly known as ALARIS MEDICAL, INC.)
(Exact name of
registrant as specified in its charter)
| Delaware (State or other jurisdiction of incorporation or organization) |
13-3492624 (I.R.S. Employer Identification Number) |
| 10221 Wateridge Circle, San Diego, California (Address of principal executive offices) |
92121 (Zip Code) |
| Registrant’s telephone number, including area code | (858) 458-7000 |
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Name of Each Exchange on Which Registered |
| Common Stock, $0.01 par value | American Stock Exchange |
Securities registered pursuant to Section 12(g) of the Act:
| None |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days. YES: [|X|] NO: ____
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [|X|]
The registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes [|X|] No [ ]
The aggregate market value of the shares of the registrant’s common stock, $0.01 par value per share (“Common Stock”), held by nonaffiliates of the registrant, computed by reference to the price at which such stock was last sold, on February 28, 2003, was $109,129,487. Solely for purposes of this calculation, the following persons, who owned in the aggregate 47,412,684 shares of Common Stock at February 28, 2003, have been deemed to be affiliates of the registrant: directors of the registrant, Executive Officers and known stockholders of the registrant owning 5% or more of the outstanding shares of Common Stock.
As of February 28, 2003, the registrant had 59,870,388 shares of Common Stock outstanding.
This Form 10-K/A is being filed solely for the purpose of correcting Exhibit 23, the Consent of Independent Accountants, to reference additional Registration Statements on Form S-8 of ALARIS Medical Systems, Inc. in such Consent, and does not reflect any events occurring after the date of filing of the original Form 10-K or otherwise modify or update any of the information contained therein, other than the change of the registrant’s name to ALARIS Medical Systems, Inc. from ALARIS Medical, Inc.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on August 26, 2003.
| ALARIS MEDICAL SYSTEMS, INC.
By: /s/ DAVID L. SCHLOTTERBECK ———————————————— David L. Schlotterbeck President and Chief Executive Officer |
| Exhibit No. | Description of Exhibit |
| 23 | Consent of PricewaterhouseCoopers LLP. |
| 31.1 | Certification by David L. Schlotterbeck Pursuant to Securities Exchange Act Rule 13a-15. |
| 31.2 | Certification by William C. Bopp Pursuant to Securities Exchange Act Rule 13a-15. |